Validation of novel secondary dystroglycanopathy genes using biochemical, cellular and zebrafish studies
Page 1 of 1
Validation of novel secondary dystroglycanopathy genes using biochemical, cellular and zebrafish studies
Jon Moulton Fri Oct 12, 2012 1:14 pm
Stevens E, Carss K, Cirak S, Torelli S, Foley AR, Sewry C, Topaloglu H, Haliloglu G, Stemple D, Hurles M, Lin YY, Muntoni F. Validation of novel secondary dystroglycanopathy genes using biochemical, cellular and zebrafish studies. Neuromusc Disord. 2012;22(9):812
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option
» Biochemical Characterization of Three BLT Receptors in Zebrafish
» BMP and non-canonical Wnt signaling are required for inhibition of secondary tail formation in zebrafish
» Shigella-Induced Emergency Granulopoiesis Protects Zebrafish Larvae from Secondary Infection
» Dioxin inhibition of swim bladder development in zebrafish: Is it secondary to heart failure?
» Biochemical Characterization of Three BLT Receptors in Zebrafish
» BMP and non-canonical Wnt signaling are required for inhibition of secondary tail formation in zebrafish
» Shigella-Induced Emergency Granulopoiesis Protects Zebrafish Larvae from Secondary Infection
» Dioxin inhibition of swim bladder development in zebrafish: Is it secondary to heart failure?
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum